| 000 | 01703 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514185728.0 | ||
| 264 | 0 | _c20041214 | |
| 008 | 200412s 0 0 eng d | ||
| 022 | _a0947-7349 | ||
| 024 | 7 |
_a10.1055/s-2004-817934 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHauner, H | |
| 245 | 0 | 0 |
_aWeight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study. _h[electronic resource] |
| 260 |
_bExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association _cApr 2004 |
||
| 300 |
_a201-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAppetite Depressants _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 |
_aCyclobutanes _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aObesity _xblood |
| 650 | 0 | 4 | _aPrimary Health Care |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aWeight Loss _xdrug effects |
| 700 | 1 | _aMeier, M | |
| 700 | 1 | _aWendland, G | |
| 700 | 1 | _aKurscheid, T | |
| 700 | 1 | _aLauterbach, K | |
| 773 | 0 |
_tExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association _gvol. 112 _gno. 4 _gp. 201-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2004-817934 _zAvailable from publisher's website |
| 999 |
_c14837359 _d14837359 |
||